FDA Drug Approval, A074450, MEXILETINE HYDROCHLORIDE

FDA Drug Approval, A074450, MEXILETINE HYDROCHLORIDE

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out

Contents: Summary Basis of Approval

ANDA: 074450
Company: ANI PHARMS
Drug Name: MEXILETINE HYDROCHLORIDE
Active Ingredients: MEXILETINE HYDROCHLORIDE
Strength: 250MG
Dosage Form/Route: CAPSULE;ORAL
Action Date: 05/16/1996
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details